Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics
- PMID: 11158605
- PMCID: PMC14719
- DOI: 10.1073/pnas.98.3.1124
Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics
Abstract
Acute myeloid leukemia (AML) is a heterogeneous group of diseases. Normal cytogenetics (CN) constitutes the single largest group, while trisomy 8 (+8) as a sole abnormality is the most frequent trisomy. How trisomy contributes to tumorigenesis is unknown. We used oligonucleotide-based DNA microarrays to study global gene expression in AML+8 patients with +8 as the sole chromosomal abnormality and AML-CN patients. CD34(+) cells purified from normal bone marrow (BM) were also analyzed as a representative heterogeneous population of stem and progenitor cells. Expression patterns of AML patients were clearly distinct from those of CD34(+) cells of normal individuals. We show that AML+8 blasts overexpress genes on chromosome 8, estimated at 32% on average, suggesting gene-dosage effects underlying AML+8. Systematic analysis by cellular function indicated up-regulation of genes involved in cell adhesion in both groups of AML compared with CD34(+) blasts from normal individuals. Perhaps most interestingly, apoptosis-regulating genes were significantly down-regulated in AML+8 compared with AML-CN. We conclude that the clinical and cytogenetic heterogeneity of AML is due to fundamental biological differences.
Figures
Similar articles
-
Impact of trisomy 8 on expression of genes located on chromosome 8 in different AML subgroups.Genes Chromosomes Cancer. 2006 Dec;45(12):1164-8. doi: 10.1002/gcc.20380. Genes Chromosomes Cancer. 2006. PMID: 17001623
-
Routine expression profiling of microarray gene signatures in acute leukaemia by real-time PCR of human bone marrow.Br J Haematol. 2005 Jul;130(2):233-48. doi: 10.1111/j.1365-2141.2005.05594.x. Br J Haematol. 2005. PMID: 16029452
-
Gene expression analysis reveals HOX gene upregulation in trisomy 8 AML.Leukemia. 2010 Jun;24(6):1239-43. doi: 10.1038/leu.2010.85. Epub 2010 Apr 29. Leukemia. 2010. PMID: 20428200 No abstract available.
-
Gene expression with prognostic implications in cytogenetically normal acute myeloid leukemia.Semin Oncol. 2008 Aug;35(4):356-64. doi: 10.1053/j.seminoncol.2008.04.006. Semin Oncol. 2008. PMID: 18692686 Review.
-
Trisomy 8 as the sole chromosomal aberration in acute myeloid leukemia and myelodysplastic syndromes.Pathol Biol (Paris). 2007 Feb;55(1):37-48. doi: 10.1016/j.patbio.2006.04.007. Epub 2006 May 11. Pathol Biol (Paris). 2007. PMID: 16697122 Review.
Cited by
-
High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression.Neoplasia. 2004 May-Jun;6(3):240-7. doi: 10.1593/neo.3439. Neoplasia. 2004. PMID: 15153336 Free PMC article.
-
Scalable Prediction of Acute Myeloid Leukemia Using High-Dimensional Machine Learning and Blood Transcriptomics.iScience. 2020 Jan 24;23(1):100780. doi: 10.1016/j.isci.2019.100780. Epub 2019 Dec 18. iScience. 2020. PMID: 31918046 Free PMC article.
-
Constitutional aneuploidy and cancer predisposition.Hum Mol Genet. 2009 Apr 15;18(R1):R84-93. doi: 10.1093/hmg/ddp084. Hum Mol Genet. 2009. PMID: 19297405 Free PMC article. Review.
-
Methods for the molecular analysis of cancer. An overview.Mol Biotechnol. 2003 Feb;23(2):167-70. doi: 10.1385/MB:23:2:167. Mol Biotechnol. 2003. PMID: 12632699 Review.
-
Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia.J Exp Med. 2010 Nov 22;207(12):2581-94. doi: 10.1084/jem.20091071. Epub 2010 Nov 8. J Exp Med. 2010. PMID: 21059853 Free PMC article.
References
-
- Orkin S H. Curr Opin Cell Biol. 1995;7:870–877. - PubMed
-
- Tenen D, Hromas R, Licht J, Zhang D. Blood. 1997;90:489–519. - PubMed
-
- Wickremasinghe R, Hoffbrand A. Blood. 1999;93:3587–3600. - PubMed
-
- Heim S, Mitelman F. Cancer Cytogenetics. New York: Wiley; 1995.
-
- Byrd J C, Lawrence D, Arthur D C, Pettenati M J, Tantravahi R, Qumsiyeh M, Stamberg J, Davey F R, Schiffer C A, Bloomfield C D. Clin Cancer Res. 1998;4:1235–1241. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases